Listed by the USPTO as PATEL, SHEFALI DILIP
Tech Center 4100 • Art Units: 3763 3767 3783 4100
This examiner grants 58% of resolved cases
This examiner works in technology center 4100 and art unit 3763. The record includes 756 resolved cases, a 58.2% allowance rate, and a median of 1412 days to allowance. Interview lift is 27.6%, showing a positive association between interviews and allowance outcomes.
The leading companies are Becton, Dickinson and Company, Sanofi S.A., and Bard Access Systems Inc. The leading firms are Bond, Schoeneck & King, PLLC - SANOFI, Knobbe, Martens, Olson & Bear, LLP, and MCDONNELL BOEHNEN HULBERT & BERGHOFF LLP. Practitioners should plan for extended prosecution and use interviews to address substantive disputes.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18105533 | Intraosseous Hemodialysis Port | Non-Final OA | Bard Access Systems, Inc. |
| 17742098 | Systems, Medical Devices, and Methods for Steering the Medical Devices | Final Rejection | Bard Access Systems, Inc. |
| 18450075 | MEDICAL DEVICES AND RELATED METHODS | Final Rejection | Boston Scientific Scimed, Inc. |
| 18669697 | MEDICAL SYSTEMS, DEVICES, AND METHODS FOR DELIVERING ONE OR MORE FLUIDS | Non-Final OA | Boston Scientific Medical Device Limited |
| 18669816 | TESTING DEVICE, TESTING METHOD, AND ELONGATED MEDICAL BODY | Non-Final OA | Terumo Kabushiki Kaisha |
| 18616678 | SURFACE TREATMENT FOR CONNECTORS | Non-Final OA | CareFusion 303, Inc. |
| 18709991 | SENSOR ARRANGEMENT FOR A BREAST PUMP DEVICE AND BREAST PUMP DEVICE USING THE SENSOR ARRANGEMENT | Non-Final OA | KONINKLIJKE PHILIPS N.V. |
| 17603315 | CUSHION CONFIGURED TO BE MOUNTED TO AN AIR PASSAGE ELEMENT OF A BREAST PUMP DEVICE | Non-Final OA | KONINKLIJKE PHILIPS N.V. |
| 17799541 | DRUG INFUSION DEVICES COMPATIBLE WITH DRUG FORMULATIONS | Non-Final OA | Medtronic, Inc. |
| 18684025 | THERAPEUTIC AGENT DELIVERY DEVICE | Non-Final OA | ELI LILLY AND COMPANY |
| 18674549 | INJECTION DEVICE FOR DRUG DELIVERY AND PACKAGING FOR THE INJECTION DEVICE | Final Rejection | AMGEN INC. |
| 18710112 | PLUNGER ROD REMOVAL FORCE METHOD AND FIXTURE | Non-Final OA | AMGEN INC. |
| 17913202 | SYSTEM FOR AIR VOLUME CORRECTION BASED ON FLUID PRESSURE AND FLOW RATE | Non-Final OA | BAYER HEALTHCARE LLC |
| 16944588 | SYSTEMS AND METHODS THAT FACILITATE TATTOO REMOVAL | Non-Final OA | THE GENERAL HOSPITAL CORPORATION |
| 18450238 | SAFETY AND ACCURACY MEASURES FOR MEDICAMENT BOLUS DELIVERY | Final Rejection | INSULET CORPORATION |
| 18573696 | KEYED STEERABLE CATHETER DEVICES, SYSTEMS, AND METHODS | Final Rejection | W. L. Gore & Associates, Inc. |
| 18254494 | NEEDLE AND SYRINGE USING SAME | Final Rejection | INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY |
| 18635482 | Two-Part Stopper and Process for Making Same | Non-Final OA | Becton, Dickinson and Company |
| 18634047 | Catheter System with Integrated Stabilization Anchor Securement | Non-Final OA | Becton, Dickinson and Company |
| 18618940 | PASSIVE SAFETY CATHETER SYSTEM AND RELATED METHODS | Non-Final OA | Becton, Dickinson and Company |
| 18431170 | INJECTION PEN | Non-Final OA | Becton, Dickinson and Company |
| 18254559 | APPARATUSES AND METHODS FOR DETECTING AN EMPTY RESERVOIR IN AN INFUSION PUMP | Non-Final OA | Becton, Dickinson and Company |
| 17977047 | LUER CONNECTOR FOR VASCULAR ACCESS DEVICES | Non-Final OA | Becton, Dickinson and Company |
| 17297604 | INTEGRATED CONNECTOR AND DISINFECTING CAP WITH RESERVOIR | Non-Final OA | Becton, Dickinson and Company |
| 18336880 | Compositions And Methods For Treating With A Combination Of Alternating Electric Fields And FGF Inhibitors | Final Rejection | NOVOCURE GMBH |
| 18475927 | Injector Device | Non-Final OA | Sanofi |
| 18009011 | SYSTEM FOR A DRUG DELIVERY DEVICE AND DRUG DELIVERY DEVICE | Non-Final OA | Sanofi |
| 18709921 | CONNECTOR COMPRISING AN ANTI-ROTATION AND ANTI-DISPLACEMENT MEANS | Final Rejection | B. Braun Melsungen AG |
| 18022956 | MEDICAL DEVICE FOR VISUALLY DISPLAYING AN INJECTION PRESSURE OF A FLUID | Non-Final OA | B. Braun Melsungen AG |
| 18035997 | MEDICAMENT DELIVERY DEVICE | Non-Final OA | SHL MEDICAL AG |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy58.2% of resolved applications examined by Shefali Dilip Patel were allowed (756 resolved cases), compared with 60.5% across Art Unit 3763 over the last five years.
This examiner's interview lift is +27.6 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Shefali Dilip Patel took 1,412 days on average from filing to allowance.
Shefali Dilip Patel examines applications in Art Unit 3763 in Tech Center 4100.